Jacobs Levy Equity Management, Inc Aquestive Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.64 - $2.57 $40,689 - $163,392	-63,577 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.28 - $4.26 $266,308 - $497,576	-116,802 Reduced 64.75%	63,577 $166,000
Q4 2021 Feb 14, 2022	BUY	$3.69 - $6.37 $278,392 - $480,584	75,445 Added 71.9%	180,379 $702,000
Q2 2021 Aug 16, 2021	SELL	$3.29 - $5.21 $110,043 - $174,264	-33,448 Reduced 24.17%	104,934 $417,000
Q1 2021 May 17, 2021	BUY	$4.17 - $6.73 $577,052 - $931,310	138,382 New	138,382 $720,000
Q3 2020 Nov 16, 2020	SELL	$4.12 - $9.09 $41,200 - $90,900	-10,000 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$1.84 - $6.44 $89,190 - $312,166	-48,473 Reduced 82.9%	10,000 $49,000
Q1 2020 May 15, 2020	BUY	$1.54 - $6.75 $51,446 - $225,497	33,407 Added 133.28%	58,473 $128,000
Q4 2019 Feb 14, 2020	SELL	$3.06 - $8.78 $272,783 - $782,693	-89,145 Reduced 78.05%	25,066 $146,000
Q3 2019 Nov 14, 2019	BUY	$3.04 - $4.91 $86,077 - $139,026	28,315 Added 32.96%	114,211 $363,000
Q2 2019 Aug 13, 2019	BUY	$3.72 - $6.95 $319,533 - $596,977	85,896 New	85,896 $361,000

120

43.3M

504K

148K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $168M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.